BioRestorative Therapies, Inc. (BRTX) NASDAQ
0.23
+0.0071(+3.19%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.23
+0.0071(+3.19%)
Currency In USD
| Market Cap | 10.61M |
| Enterprise Value | 9.1M |
| P/E Ratio | -0.14 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 5.75 |
| Price/Book Ratio | 5.72 |
| Enterprise/Revenue | 1.55 |
| Enterprise/EBITDA | -0.04 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -39.59 |
| Operating Margin | -43.5 |
| Return On Assets | -3.49 |
| Return On Equity | -4.2 |
| Revenue | 359,700 |
| Revenue/Share | 0.04 |
| Gross Profit | 335,856 |
| EBITDA | -15.44M |
| Net Income | -14.24M |
| Diluted EPS | -1.58 |
| Total Cash | 2.95M |
| Total Cash/Share | 0.33 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0.84 |
| Book Value Per Share | 0.04 |
| 52-Week Change | -86.56 |
| 52-Week High | 2.05 |
| 52-Week Low | 0.19 |
| Moving Average 50 Days | 0.26 |
| Moving Average 200 Days | 1.09 |
| Average Volume | 9.49M |
| Shares Outstanding | 8.99M |
| % Held by Institutions | 3.59 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0 |
| Last Split Factor | 1:4000 |
| Last Split Date | October 27, 2021 |